What's in DreaMed Diabetes's pipeline?

DreaMed Diabetes has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with DreaMed Diabetes's portfolio?

Top competitors by shared drug class: Biodel, Eli Lilly and Company, Hospital Universitario Dr. Jose E. Gonzalez, Institute for Clinical and Experimental Medicine, Kinderkrankenhaus auf der Bult.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dreamed-diabetes.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

DreaMed Diabetes — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DreaMed Diabetes pipeline: 1 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Multiple Daily Injections of Insulin	Multiple Daily Injections of Insulin	marketed	Insulin	Insulin receptor	Diabetes

Therapeutic area mix

Diabetes · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biodel · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Hospital Universitario Dr. Jose E. Gonzalez · 1 shared drug class
Institute for Clinical and Experimental Medicine · 1 shared drug class
Kinderkrankenhaus auf der Bult · 1 shared drug class
Mackay Memorial Hospital · 1 shared drug class
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 1 shared drug class
American Heart Association · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for DreaMed Diabetes:

Cite this brief

Drug Landscape (2026). DreaMed Diabetes — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dreamed-diabetes. Accessed 2026-05-18.